Psoriasis trials in China
10 of 49 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationMass Spectrometry-based Immune Profiling in Autoimmune Diseases
- Where
- Beijing
- Age
- 18 years and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07188285 - No phaseNot yet taking people in ChinaEffects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
- Where
- Nanjing
- Age
- 18 years and over
- People
- 120
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07642544 - No phaseEnrolling by invitationA Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 50
- Run by
- Xi Tan
See details and how to joinNCT06999941 - No phaseNot yet taking people in ChinaResearch on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 450
- Run by
- Shanghai Yueyang Integrated Medicine Hospital
See details and how to joinNCT07351448 - No phaseTaking peopleA Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
- Where
- Nanjing
- Age
- 18 years and over
- People
- 50
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06987292 - No phaseTaking peoplePhase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
- Where
- Shenyang
- Age
- 18 years and over
- People
- 1,516
- Run by
- First Hospital of China Medical University
See details and how to joinNCT06696417 - No phaseNot yet taking people in ChinaReal-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
- Where
- Hunan
- Age
- 18 years and over
- People
- 1,000
- Run by
- Chongqing Genrix Biopharmaceutical Co., Ltd
See details and how to joinNCT06802848 - No phaseNot yet taking people in ChinaA Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 10,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06766552 - No phaseTaking peopleProspective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
- Where
- Nanjing
- Age
- 18 years and over
- People
- 400
- Run by
- Nanjing Medical University
See details and how to joinNCT06730334 - No phaseTaking peopleChinese Psoriasis Real World Evidence Research
- Where
- Beijing, Chongqing, Fujian, Gansu, Guangdong, Guangxi, Guizhou, Hainan, Hangzhou, Hebei, Heilongjiang, Henan, Hohhot, Hubei, Hunan, Jiangxi, Jilin City, Nanjing, Qinghai, Shandong, Shanghai, Shanxi, Shenyang, Sichuan, Tianjin, Xinjiang, Yinchuan, Yunnan
- People
- 10,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04465838